Clinical trials recruiting for Uveal Melanoma

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or Angiosarcoma
  NCT05607095 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
  NCT06805825 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 5 locations
• Adding IL-2 to Tebentafusp to Eradicate Cancer Progression
  NCT07063875 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Adjuvant Melatonin for Uveal Melanoma
  NCT05502900 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Adjuvant Quisinostat in High-Risk Uveal Melanoma
  NCT06932757 · Phase: Phase 2 · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• Adjuvant Tebentafusp in High Risk Ocular Melanoma
  NCT06246149 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 15 locations
• Assessing the Clinical Effectiveness of Serum Biomarkers in the Diagnosis of Metastatic Uveal Melanoma
  NCT01438658 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Choroidal Melanoma Patient-Reported Outcome Study (CM-PRO) in a Subset of AU-011-301 (CoMpass) Subjects
  NCT07421739 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME)
  NCT04424719 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
  NCT04792463 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
  NCT04119024 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 3 locations
• Identification of New Candidate Genes for Hereditary Predisposition to Uveal Melanoma
  NCT06550674 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Immune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the Liver
  NCT07364474 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Neoadjuvant Darovasertib in Primary Uveal Melanoma
  NCT07015190 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 94 locations
• Neoadjuvant Immunotherapy for Patients With High-risk Eye Melanoma
  NCT07501117 · Phase: Phase 1 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• PHP in Combination With IPI1/NIVO3 Compared to IPI3/NIVO1 Only in Patients With Uveal Melanoma Liver Metastases
  NCT06519266 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• Retrospective Register for Uveal Melanoma
  NCT05733728 · Phase: Not specified · Ages: 18 Years to 99 Years · Sex: All (male and female) · 1 location
• Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma
  NCT06070012 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations

Related conditions

Trials recruiting for Uveal Melanoma often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Uveal Melanoma trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.